Renal Sympathetic Denervation in Patients with Resistant Hypertension : A Feasibility Study

BACKGROUND/AIMS: We assessed the feasibility of renal sympathetic denervation (RDN) treatment in patients with resistant hypertension using the Iberis® RDN system. This study was a prospective, multicenter, single-arm feasibility registry.

METHODS: We collected data from patients who underwent RDN treatment using the Iberis system. From November 2014 to February 2016, 16 patients from 6 centers in Europe were enrolled in this registry.

RESULTS: Consistent reductions in the 24-h systolic blood pressure (SBP) and diastolic blood pressure were obtained. At any follow-up point, more than 70% of the patients were responders. The change in the 24-h SBP at 1 month was strongly correlated with that at 12 months.

CONCLUSION: The Iberis system is safe and effective in patients for the treatment of resistant hypertension. Furthermore, our results suggest that we can estimate the effect of RDN in the long term at the 1-month follow-up point using the 24-h SBP.

Medienart:

E-Artikel

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Zur Gesamtaufnahme - volume:6

Enthalten in:

Pulse (Basel, Switzerland) - 6(2019), 3-4 vom: 24. Apr., Seite 137-143

Sprache:

Englisch

Beteiligte Personen:

Kario, Kazuomi [VerfasserIn]
Rumoroso, Jose Ramon [VerfasserIn]
Okawara, Yukie [VerfasserIn]
Pérez de Prado, Armando [VerfasserIn]
Garcia Fernandez, Eulogio [VerfasserIn]
Kagitani, Hideaki [VerfasserIn]
Goicolea Gómez, Francisco Javier [VerfasserIn]
Rodríguez Leor, Oriol [VerfasserIn]
Stankovic, Goran [VerfasserIn]

Links:

Volltext

Themen:

Ambulatory blood pressure measurement
First-generation radiofrequency catheter
Journal Article
Renal sympathetic denervation
Resistant hypertension
Responder

Anmerkungen:

Date Revised 08.04.2022

published: Print-Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.1159/000490620

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM296688878